Compare Expeditors International of Wshngtn Inc (EXPD) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expeditors International of Wshngtn Inc vs Johnson & Johnson — how do they compare? Expeditors International of Wshngtn Inc trades at $182.22 (market cap $23.04B), while Johnson & Johnson trades at $260.46 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 27.2× Expeditors International of Wshngtn Inc's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| EXPD | JNJ | |
|---|---|---|
Market Cap | $23.04B | $626.09B |
Sector | Industrials | Health |
52-Week High | $182.80 | $267.24 |
52-Week Low | $113.13 | $172.78 |
Enterprise Value | $22.57B | $654.37B |
Dividend Yield | 0.91% | 2.06% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXPD trades at $182.11, up 1.74% today, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings of $2.03 per share, beating estimates, driven by airfreight and customs demand. Revenue for 2025 was $11.07B, with a net income margin of 7.63% and robust ROE of 42.6%. Recent news highlights growth from tariff policies but notes ocean freight contraction.
Outlook is mixed; earnings momentum and high profitability support upside, but analyst consensus is Hold with a $181.14 target, near current price. Risks include unsustainable growth from temporary factors and competitive pressures. The stock's valuation at a P/E of 25.79 appears fair given earnings beats, but caution is warranted if ocean freight weakness persists.
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
